Replies to post #19675 on Intellect Neurosciences Inc. (fka ILNS)

[Stately]

Try again. Go to the paper and click the button by "author information" and tell me who the first two authors work for.

[Stately]

I'm not understanding what you're saying here...the company's last PR was about a scientific paper that was correlated to their license programs. How is this different? Are you agreeing or disagreeing that this means Pfizer wants to move forward with ponezumab for CAA?